Medical Treatment for Acute Appendicitis

• Sponsor: Uşak University (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04594486
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Anticipated Duration (Months): 59
• Patients Per Site Per Month: 1.7

Study Details

Study Description

Brief Summary

Medical treatment for acute appendicitis

Condition or Disease	Intervention/Treatment	Phase
Acute Appendicitis	Other: Medical treatment of acute appendicitis

Detailed Description

Patients with clinically and radiologically approved acute appendicitis will be treated medically. The main aim of the study is to define the long term results of medical treatment for acute appendicitis. Patients will be followed by clinical visits and recurrences will be recorded.

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 100 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Long Term Results of Medical Treatment for Acute Appendicitis
• Actual Study Start Date: Feb 1, 2017
• Anticipated Primary Completion Date: Dec 1, 2021
• Anticipated Study Completion Date: Jan 1, 2022

Outcome Measures

Primary Outcome Measures

1. recuurence [5 years]

   recuurent acute appendicitis

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All

Inclusion Criteria:

• clinically and radiologically approved acute appendicitis

• approved and signed the informed consent form

Exclusion Criteria:

• perforated cases

• cases with peritonitis

• patient wish for surgical treatment

• allergy to drugs used in medical treatment of acute appendicitis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Uşak University	Uşak		Turkey	64200

Sponsors and Collaborators

• Uşak University

Investigators

• Principal Investigator: Barış Sevinç, M.D., Uşak University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Barış Sevinç, Assoc. Prof., Uşak University
• ClinicalTrials.gov Identifier: NCT04594486
• Other Study ID Numbers: app001
• First Posted: Oct 20, 2020
• Last Update Posted: Oct 20, 2020
• Last Verified: Oct 1, 2020

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Appendicitis; Acute Disease

Study Results

No Results Posted as of Oct 20, 2020